Efficacy of remimazolam versus midazolam for procedural sedation: post hoc integrated analyses of three phase 3 clinical trials
Background and study aims Remimazolam is an ultra-short acting, fast onset/fast offset benzodiazepine for intravenous use in procedural sedation, general anesthesia, and Intensive Care Unit sedation. The aim of this work was to compare the efficacy of remimazolam versus midazolam dosed according to...
Main Authors: | Van-Anh Dao, Frank Schippers, Thomas Stöhr |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2022-04-01
|
Series: | Endoscopy International Open |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/a-1743-1936 |
Similar Items
-
Efficacy and Safety Profile of Remimazolam for Sedation in Adults Undergoing Short Surgical Procedures
by: Morimoto Y
Published: (2022-02-01) -
Remimazolam versus propofol for procedural sedation: a meta-analysis of randomized controlled trials
by: Yu Chang, et al.
Published: (2023-06-01) -
Remimazolam for Pediatric Procedural Sedation: Results of an Institutional Pilot Program
by: Tatsuya Hirano, et al.
Published: (2023-09-01) -
The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography
by: Dan‐Dan Tan, et al.
Published: (2023-09-01) -
Midazolam for procedural sedation in adults and children. Literature review
by: Yuliana Babina, et al.
Published: (2024-02-01)